Finally, a day of gains for the AIM All Share – even if it was a modest three points – to leave the index at 711.47, tracking higher in line with many other global indices.
- Trellus Health +65%
- Celadon Pharmaceuticals +41%
- NAHL +8%
- Image Scan -22%
- Seeing Machines -21%
Trellus Health LON:TRLS was the biggest riser but there’s no news here. The company announced a deal with Johnson & Johnson six weeks ago so is there an update coming here?
- AIM Market Roundup: Trellus, Falcon Oil, MyHealthChecked
- AIM Market Roundup: Blue Star Capital, Trellus Health, Distil
Celadon Pharmaceuticals LON:CEL was 41% higher with mid-session news of a newly committed credit facility being the driver. Under the terms of the Facility, Celadon is permitted to use the proceeds for general corporate purposes including funding of working capital, capital expenditure and up to £0.45m in fees, costs and expenses.
- AIM Market Roundup: Rome Resources, Celadon Pharmaceuticals, Churchill China
- AIM Market Roundup: Minoan Group, Invinity Energy, Thor Exploration
NAHL Group LON:NAH gets the notable mention, up 8% on the day. There have been a couple of disclosable transactions reported today but volumes, whilst elevated, have been far from remarkable.
Image Scan LON:IGE was the biggest faller, off 22% on the day. There’s no news here however beyond the fact that resolutions at today’s AGM all passed.
Seeing Machines LON:SEE was the second biggest faller, off 21%. The company published H1 numbers and a trading update this morning and whilst there were positives in there in terms of uptake and falling expenses, revenues were flat with the company also noting QoQ production dropping.
